PROmotion of FLU Vaccine Uptake in the Emergency Department - PROFLUVAXED
- Conditions
- Influenza Vaccination
- Interventions
- Other: Question (Q)Other: Messaging (M)
- Registration Number
- NCT05836818
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
The goal of this research is to increase influenza vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and focus groups with ED Usual Source of Care Patients and community partners and produce trusted messaging informational platforms (PROmotion of FLU VA(X)ccination in the Emergency Department - PROFLUVAXED) that will address barriers to flu vaccination, especially vaccine hesitancy. The investigators will then conduct a cluster-randomized, controlled trial of PROFLUVAXED platforms in six EDs to determine whether their implementation is associated with greater flu vaccine acceptance and uptake in ED Usual Source of Care Patients.
- Detailed Description
Specific Aim I: To determine whether implementation of influenza vaccine trusted messaging platforms is associated with increased influenza vaccine uptake in unvaccinated ED patients.
At six EDs (Zuckerberg San Francisco General, UCSF Parnassus Medical Center \[San Francisco, CA\], Thomas Jefferson University Hospital \[Philadelphia, PA\], Ben Taub Hospital \[Houston, TX\], Harborview Medical Center \[Seattle, WA\], and Duke University Medical Center \[Durham, NC\]), investigators will conduct a cluster-randomized controlled trial of implementation of PROFLUVAXED trusted messaging platforms, with influenza vaccine uptake in the ED as the primary outcome. Hypothesis: Implementation of PROFLUVAXED trusted messaging platforms in EDs will be associated with increased influenza vaccine uptake in unvaccinated ED patients.
Specific Aim II: To determine whether implementation of influenza vaccine trusted messaging platforms in EDs is associated with increased influenza vaccine acceptance in unvaccinated ED patients. For this specific aim influenza vaccine acceptance in the ED assessed via ED survey will be the primary outcome. Hypothesis: Implementation of PROFLUVAXED trusted messaging platforms in EDs will be associated with increased influenza vaccine acceptance in unvaccinated ED patients.
Specific Aim III: To determine whether implementation of a protocol in which ED patients are asked whether they will accept an influenza vaccine in the ED (and notifying ED providers when they say they will accept it) is associated with increased influenza vaccine uptake in unvaccinated ED patients. Hypothesis: Implementation of an ED protocol in which patients are asked whether they will accept an influenza vaccine (and notifying ED providers when they say they will accept it) will be associated with increased influenza vaccine uptake in unvaccinated ED patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 776
- Adults
- Presenting to ED
- Not already vaccinated for influenza in the current year
- Able to provide informed consent
- Fluent in English or Spanish
- Anticipated ability to complete study intervention in ED i.e., able to watch a 3-minute videoclip
- Age < 18 years
- Major trauma such that it will preclude survey
- Inability to participate in a survey because of intoxication, altered mental status, or critical illness
- Incarceration
- Psychiatric hold
- We will also exclude patients who state that they have already received an influenza vaccine and patients who are in the ED for suspected acute Covid or influenza illness.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Messaging (M) Question (Q) Subjects receive vaccine messaging and are asked a question about whether they would accept a vaccine Messaging (M) Messaging (M) Subjects receive vaccine messaging and are asked a question about whether they would accept a vaccine Question (Q) Question (Q) Subjects receive no vaccine messaging, but are asked a question about whether they would accept a vaccine
- Primary Outcome Measures
Name Time Method Influenza Vaccine Uptake at 30 Days Comparing Intervention M and Non Intervention 30 days post index ED visit Participant uptake of the influenza vaccine 30 days after enrollment assessed by confirmation of receipt of vaccine in one of 3 ways:
1. Receipt in emergency department during index (enrollment) visit
2. Electronic health record review 30 days after index visit
3. Follow up phone call to participant at 30 days - We are asking patients if they received a flu vaccine since their index emergency department visit.
- Secondary Outcome Measures
Name Time Method Vaccine Acceptance during ED visit Participants who responded they would accept a vaccine of asked in the ED. Comparing Intervention M and Intervention Q groups
Influenza Vaccine Uptake at 30 Days Comparing Intervention Q and Non-Intervention Group 30 days post index ED visit Participant uptake of the influenza vaccine 30 days after enrollment assessed by confirmation of receipt of vaccine in one of 3 ways:
1. Receipt in emergency department during index (enrollment) visit
2. Electronic health record review 30 days after index visit
3. Follow up phone call to participant at 30 days - We are asking patients if they received a flu vaccine since their index emergency department visit.
Trial Locations
- Locations (8)
Thomas Jefferson University Hospital
🇺🇸Philadelphia, Pennsylvania, United States
Jefferson Torresdale Hospital
🇺🇸Philadelphia, Pennsylvania, United States
Baylor College of Medicine
🇺🇸Houston, Texas, United States
San Francisco General Hospital Emergency Department
🇺🇸San Francisco, California, United States
University of California San Francisco Parnassus
🇺🇸San Francisco, California, United States
Jefferson Methodist Hospital
🇺🇸Philadelphia, Pennsylvania, United States
University of Washington-Harborview Emergency Department
🇺🇸Seattle, Washington, United States
Duke University Hospital
🇺🇸Durham, North Carolina, United States